Johnston K W
Department of Surgery, University of Toronto Study Coordinator, Ontario, Canada.
J Vasc Surg. 1994 Aug;20(2):163-70. doi: 10.1016/0741-5214(94)90002-7.
Based on the prospective analysis of data on 680 patients undergoing surgery for nonruptured abdominal aortic aneurysm (AAA) and recorded in the Canadian Society for Vascular Surgery Aneurysm Registry, this study determines the late survival rate by comparison to an age- and sex-matched population, the causes of late death, the effect of heart-related death on late survival, and the prognostic variables that are associated with late survival.
To identify the variables that were associated with survival, statistical methods included Kaplan-Meier analysis and Cox regression analysis. The Canadian Society for Vascular Surgery Aneurysm Registry provided ongoing current follow-up of patients.
The survival rate was 94.6% at 1 month, 90.7% at 1 year, 87.1% at 2 years, 81.0% at 3 years, 74.0% at 4 years, 67.7% at 5 years, and 60.2% at 6 years. The late survival rate of patients with AAA is significantly less than the age- and sex-matched normal population (60.2% versus 79.2%). In the AAA group, heart-related causes of late death (44.4% versus 34.1%) and cerebrovascular causes (8.3% versus 5.8%) were more frequent. The calculated 5-year heart-related mortality rate is 14.3%. This is higher than the heart-related mortality rate for the age- and sex-matched population, which is 6.4%. Hence, the risk of heart-related death for patients who have undergone AAA repair is increased by 1.6% per year. Vascular complications from aortic aneurysm repair or recurrent aneurysmal disease were an uncommon cause of late death: ruptured thoracic aneurysm, 1.5%; ruptured aortic false aneurysm, 1.5%; and aortoenteric fistula, 0%. This incidence appears to be less than reported in earlier series. By Cox regression analysis, the variables that were significant predictors of a lower late survival rate were increased age, preoperative electrocardiogram indicating a previous myocardial infarction, and elevated serum creatinine levels.
Because cardiac complications accounted for 68.8% (22/32) of the 4.7% in-hospital mortality rate (i.e., a heart-related mortality rate of 3.2%), it seems reasonable to develop a strategy to reduce the cardiac operative risk by identifying and treating patients at high risk before operation. However, it is doubtful that a preoperative program that screens and treats all patients can be cost-effective in preventing late heart-related deaths.
基于对加拿大血管外科学会动脉瘤登记处记录的680例未破裂腹主动脉瘤(AAA)手术患者数据的前瞻性分析,本研究通过与年龄和性别匹配的人群进行比较,确定晚期生存率、晚期死亡原因、心脏相关死亡对晚期生存的影响以及与晚期生存相关的预后变量。
为了确定与生存相关的变量,统计方法包括Kaplan-Meier分析和Cox回归分析。加拿大血管外科学会动脉瘤登记处对患者进行持续的当前随访。
1个月时生存率为94.6%,1年时为90.7%,2年时为87.1%,3年时为81.0%,4年时为74.0%,5年时为67.7%,6年时为60.2%。AAA患者的晚期生存率显著低于年龄和性别匹配的正常人群(60.2%对79.2%)。在AAA组中,心脏相关的晚期死亡原因(44.4%对34.1%)和脑血管原因(8.3%对5.8%)更为常见。计算得出的5年心脏相关死亡率为14.3%。这高于年龄和性别匹配人群的心脏相关死亡率,即6.4%。因此,接受AAA修复的患者心脏相关死亡风险每年增加1.6%。主动脉瘤修复或复发性动脉瘤疾病引起的血管并发症是晚期死亡的罕见原因:破裂的胸主动脉瘤,1.5%;主动脉假性动脉瘤破裂,1.5%;主动脉肠瘘,0%。这一发生率似乎低于早期系列报道。通过Cox回归分析,晚期生存率较低的显著预测变量是年龄增加、术前心电图显示既往心肌梗死以及血清肌酐水平升高。
由于心脏并发症占4.7%的住院死亡率中的68.8%(22/32),即心脏相关死亡率为3.2%,因此制定一项通过在术前识别和治疗高危患者来降低心脏手术风险的策略似乎是合理的。然而,对所有患者进行筛查和治疗的术前方案能否在预防晚期心脏相关死亡方面具有成本效益,这值得怀疑。